Autologous stem cell transplantation (ASCT) in patients with mantle cell lymphoma: a retrospective study of the Spanish lymphoma group (GELTAMO)-Reference-Cited by-同舟云学术

Autologous stem cell transplantation (ASCT) in patients with mantle cell lymphoma: a retrospective study of the Spanish lymphoma group (GELTAMO)

Published:2017-05-24 Issue:8 Volume:96 Page:1323-1330
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

García-Noblejas A.,Cannata-Ortiz J.,Conde E.,González Barca E.,Gutiérrez N.,Rojas R.,Vidal M.J.,Ramírez M.J.,Jiménez-Ubieto A.,García-Ruiz J.C.,Sancho J. M.,López A.,Ríos Rull P.,Novelli S.,Albo C.,Debén G.,López-Guillermo A.,Nicolás C.,González de Villambrosia S.,Mercadal S.,Martín García-Sancho A.,Arranz R.

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

http://link.springer.com/article/10.1007/s00277-017-2998-6/fulltext.html

Reference19 articles.

1. Zhou Y, Wang H, Fang W, Romaguer JE, Zhang Y, Delasalle KB et al (2008) Incidence trends of mantle cell lymphoma in the United States between 1992 and 2004. Cancer 113:791–798

2. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H et al (2008) Mantle cell lymphoma. In “WHO classification of tumours of haematopoietic and lymphoid tissues”. 4th edition. Lyon. IARC Press:229–232

3. Dreyling M, Hiddemann W (2009) Current treatment standards and emerging strategies in mantle cell lymphoma. Hematology Am Soc Hematol Educ Program:542–551

4. Lefrère F, Delmer A, Suzan F, Levy V, Belanger C, Djabarri M et al (2002) Sequential chemotherapy by CHOP and DHAP regimens followed by high-dose therapy with stem cell transplantation induces a high rate of complete response and improves event-free survival in mantle cell lymphoma: a prospective study. Leukemia 16(4):587–593

5. Romaguera JE, Fayad L, Rodriguez MA, Broglio KR, Hagemeister FB, Pro B et al (2005) High rate of durable remissions after treatment of newly diagnosed aggressive mantle-cell lymphoma with rituximab plus hyper-CVAD alternating with rituximab plus high-dose methotrexate and cytarabine. J Clin Oncol 23(28):7013–7023

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CD34+ Cell Mobilization, Autograft Cellular Composition and Outcome in Mantle Cell Lymphoma Patients;Transfusion Medicine and Hemotherapy;2023

2. Hematopoietic Cell Transplantation;Holland‐Frei Cancer Medicine;2022-10-21

3. Autologous Hematopoietic Stem Cell Transplantation for Non-Hodgkin Lymphoma;Hematopoietic Cell Transplantation for Malignant Conditions;2019

4. Phosphoinositide-dependent protein kinase 1 is a potential novel therapeutic target in mantle cell lymphoma;Experimental Hematology;2018-03